Startups
How digital health VC funding evolved in 2024
Big-name funds like a16z and General Catalyst are becoming more influential in the space.
Big-name funds like a16z and General Catalyst are becoming more influential in the space.
J&J, Eli Lilly, and GSK all made deals on Monday morning.
The health benefits startup is acquiring Accolade at $7.03 per share—double its prior day’s closing number.
Private equity firms Apollo Global Management and Leonard Green & Partners were the focus of the report.
The chain is reportedly in talks for a deal with private equity firm Sycamore Partners.
The VC giant wants to use the system as a testing ground for health tech developed by its portfolio companies.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.